Walmart (NYSE:WMT | WMT Price Prediction) trades at $116.89, with the post-earnings pullback offering a more attractive entry into a defensive retailer whose digital flywheel keeps accelerating against a sticky inflation backdrop.
Walmart runs the world’s largest brick-and-mortar retail footprint, spanning 10,900+ stores across 19 countries and serving roughly 280 million weekly customers. It also operates Sam’s Club, Walmart International, and a fast-growing digital, advertising, and membership business that increasingly drives profit.
Shares peaked above $130 around the Q1 FY27 release, then drifted lower as investors digested a thin EPS beat, negative free cash flow, and an inventory build. The stock is down 10.14% over the past month, even as the underlying business kept compounding.
Why the Digital Flywheel Justifies the Premium
The bull case rests on mix shift. Global eCommerce grew 26% in Q1 FY27 and now represents 23% of net sales, while global advertising jumped 37% and membership fee revenue rose 17.4%. These are the highest-margin lines on the P&L, scaling on top of a U.S. comp of +4.1% ex-fuel.
Macro reinforces the setup. CPI sits at 332.4, a 12-month high, while U.S. retail sales hit $757.1B in April, also a 12-month peak. Walmart is logging its strongest share gains in five years in general merchandise, led by upper-income households trading down. Management reiterated FY27 adjusted EPS guidance of $2.75 to $2.85 and authorized a $30B buyback with $28.2B remaining.
Why a 42x Multiple Looks Stretched
The bear case starts with valuation. WMT trades at a P/E of 42 on a 3.07% net margin and a 1.60% free cash flow yield. That is a software-style multiple stapled to a low-single-digit-margin retailer.
Operational cracks emerged in Q1. Free cash flow turned negative at -$1.9 billion, capex jumped 34%, and inventory grew 8.9%. Maximum Fair Pricing legislation created a 700 bps headwind in Health & Wellness, and IEEPA tariff exposure is unquantified. Insider activity leans bearish, with the Walton Family Holdings Trust selling more than 3.8 million shares between May 22 and May 29 at prices above today’s quote.
Why Patience Has Real Appeal Here
Hold investors will note the multiple has not reset materially. Execution is solid, but the FY27 EPS guide was reiterated rather than raised, and the Q1 EPS beat was only +0.2%. A cleaner tariff outcome, a return to positive free cash flow, or a deeper multiple reset would strengthen the bull setup. The Q2 earnings report, which guides to EPS of $0.72 to $0.74, will likely settle the debate.
Where the Numbers Stand After the Drop
WMT trades at $116.89, down 10.14% over the past month and 10.9% from the filing-day close of $131.30. Over that same window, the S&P 500 rose 1.5%, leaving Walmart sharply lower versus the benchmark. Shares are still up 17.89% over the past year and 163.48% over five years.
Valuation runs rich at a P/E of 42 and P/FCF of 62, with a dividend yield of 0.81% and ROE of 22.97%. Retail sentiment is constructive, with a recent r/wallstreetbets thread titled “WMT recovery play ($14k in options)” registering a 72 bullish sentiment score.
Where the Setup Stands at $116.89
At $116.89, the setup looks constructive. The path to appreciation runs through the high-margin trio: ads up 37%, eCommerce up 26%, and membership up 17.4%. These lines grow multiples faster than the consolidated top line and structurally lift operating margin, even with headline net margin stuck near 3%. The reiterated FY27 guide and $28.2B in remaining buyback authorization provide a floor while the digital mix compounds.
The risk window is the next two quarters. A tariff escalation, a second consecutive negative FCF quarter, or an inventory build above 10% would invalidate the thesis. A clean Q2 inside the $0.72 to $0.74 range should be enough to re-rate shares back toward the prior $130 zone.
The Walton trust selling is real, but it occurred at higher prices and reflects ongoing diversification by the family office. With shares roughly 11% below their filing-day high and the operating story intact, the risk-reward at $116.89 favors patient buyers underwriting a three to five-year compounding story.
Top Gaining Stocks
Top Losing Stocks